AMPs can be used as therapeutic agents in various ways: as monotherapies for infections, in combination with conventional antibiotics to promote synergistic or additive effects, as immunomodulatory agents to enhance innate immunity, and as endotoxin‐neutralizing agents to prevent fatal complications associated with virulent factors that cause septic shock.[93] In a study by Xiong et al.,[94] a monotherapy based on transitional antimicrobial polypeptides was developed. This evidence concerns the gene ADSL and infection.